BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29357308)

  • 1. Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk.
    Corlier F; Hafzalla G; Faskowitz J; Kuller LH; Becker JT; Lopez OL; Thompson PM; Braskie MN
    Neuroimage; 2018 May; 172():118-129. PubMed ID: 29357308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
    Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
    JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
    Supiyev A; Karlsson R; Wang Y; Koch E; Hägg S; Kauppi K
    Neurobiol Aging; 2023 Jun; 126():103-112. PubMed ID: 36965205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.
    Rao SM; Bonner-Jackson A; Nielson KA; Seidenberg M; Smith JC; Woodard JL; Durgerian S
    Neuroimage; 2015 May; 111():136-46. PubMed ID: 25687593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan.
    Wang Y; Grydeland H; Roe JM; Pan M; Magnussen F; Amlien IK; Watne LO; Idland AV; Bertram L; Gundersen TE; Pascual-Leone A; Cabello-Toscano M; Tormos JM; Bartres-Faz D; Drevon CA; Fjell AM; Walhovd KW
    Brain Behav Immun; 2022 Feb; 100():243-253. PubMed ID: 34920091
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Garcia AR; Finch C; Gatz M; Kraft T; Eid Rodriguez D; Cummings D; Charifson M; Buetow K; Beheim BA; Allayee H; Thomas GS; Stieglitz J; Gurven MD; Kaplan H; Trumble BC
    Elife; 2021 Sep; 10():. PubMed ID: 34586066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population.
    Gu Y; Vorburger R; Scarmeas N; Luchsinger JA; Manly JJ; Schupf N; Mayeux R; Brickman AM
    Brain Behav Immun; 2017 Oct; 65():150-160. PubMed ID: 28457809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in brain aging among adults with family history of Alzheimer's disease and APOE4 genetic risk.
    Subramaniapillai S; Rajagopal S; Snytte J; Otto AR; ; Einstein G; Rajah MN
    Neuroimage Clin; 2021; 30():102620. PubMed ID: 33857772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
    Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
    Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    Reiter K; Nielson KA; Durgerian S; Woodard JL; Smith JC; Seidenberg M; Kelly DA; Rao SM
    J Alzheimers Dis; 2017; 55(4):1363-1377. PubMed ID: 27834774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain.
    Felsky D; Patrick E; Schneider JA; Mostafavi S; Gaiteri C; Patsopoulos N; Bennett DA; De Jager PL
    Mol Neurodegener; 2018 Jul; 13(1):38. PubMed ID: 30041668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults.
    Harrison TM; Mahmood Z; Lau EP; Karacozoff AM; Burggren AC; Small GW; Bookheimer SY
    eNeuro; 2016; 3(3):. PubMed ID: 27482534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
    Mormino EC; Betensky RA; Hedden T; Schultz AP; Ward A; Huijbers W; Rentz DM; Johnson KA; Sperling RA; ; ;
    Neurology; 2014 May; 82(20):1760-7. PubMed ID: 24748674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.
    Donix M; Burggren AC; Scharf M; Marschner K; Suthana NA; Siddarth P; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Werner A; von Kummer R; Sauer C; Small GW; Holthoff VA; Bookheimer SY
    Psychiatry Res; 2013 Dec; 214(3):212-20. PubMed ID: 24080518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.